1. Home
  2. LGND vs CVI Comparison

LGND vs CVI Comparison

Compare LGND & CVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • CVI
  • Stock Information
  • Founded
  • LGND 1987
  • CVI 1906
  • Country
  • LGND United States
  • CVI United States
  • Employees
  • LGND 68
  • CVI N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • CVI Integrated oil Companies
  • Sector
  • LGND Health Care
  • CVI Energy
  • Exchange
  • LGND Nasdaq
  • CVI Nasdaq
  • Market Cap
  • LGND 3.2B
  • CVI 3.2B
  • IPO Year
  • LGND 1992
  • CVI 2007
  • Fundamental
  • Price
  • LGND $184.49
  • CVI $36.67
  • Analyst Decision
  • LGND Strong Buy
  • CVI Strong Sell
  • Analyst Count
  • LGND 8
  • CVI 3
  • Target Price
  • LGND $144.71
  • CVI $23.33
  • AVG Volume (30 Days)
  • LGND 139.7K
  • CVI 2.1M
  • Earning Date
  • LGND 08-05-2025
  • CVI 10-27-2025
  • Dividend Yield
  • LGND N/A
  • CVI N/A
  • EPS Growth
  • LGND N/A
  • CVI N/A
  • EPS
  • LGND N/A
  • CVI N/A
  • Revenue
  • LGND $181,488,000.00
  • CVI $7,188,000,000.00
  • Revenue This Year
  • LGND $18.41
  • CVI N/A
  • Revenue Next Year
  • LGND $18.87
  • CVI $6.04
  • P/E Ratio
  • LGND N/A
  • CVI N/A
  • Revenue Growth
  • LGND 53.40
  • CVI N/A
  • 52 Week Low
  • LGND $81.74
  • CVI $15.10
  • 52 Week High
  • LGND $129.90
  • CVI $38.30
  • Technical
  • Relative Strength Index (RSI)
  • LGND 79.42
  • CVI 65.17
  • Support Level
  • LGND $179.40
  • CVI $35.70
  • Resistance Level
  • LGND $184.26
  • CVI $38.30
  • Average True Range (ATR)
  • LGND 4.60
  • CVI 1.21
  • MACD
  • LGND 0.44
  • CVI -0.13
  • Stochastic Oscillator
  • LGND 100.00
  • CVI 56.51

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About CVI CVR Energy Inc.

CVR Energy Inc is a holding company that engages in petroleum refining and nitrogen fertilizer manufacturing through its subsidiaries. Subsidiaries include several complex, full-coking crude oil refineries, along with a crude oil gathering system, pipelines and storage tanks, and marketing and supply. The company's refineries can process blends of a variety of crude oil ranging from heavy sour to light sweet crude oil. Crude oil for CVR's refineries is supplied through its wholly-owned gathering system and pipeline. From its refineries, CVR supplies products through tanker trucks directly to customers located in close geographic proximity and customers at throughput terminals. The company's customers include retailers, railroads, and farm cooperatives.

Share on Social Networks: